Epidemiologia e distribuição de lesões extrarrenais de uremia em 161 cães

Resumo: Com o objetivo de determinar a epidemiologia e as características morfológicas, incluindo a localização anatômica, das lesões extrarrenais de uremia, bem como determinar as principais lesões do sistema urinário associadas à ocorrência de uremia, foram revisados os protocolos de necropsias de cães realizadas no Laboratório de Patologia Veterinária da Universidade Federal de Santa Maria de janeiro de 1996 a dezembro de 2012 (17 anos). Nesse período foram necropsiados 4.201 cães, sendo que 161 (3,8%) apresentaram lesões extrarrenais de uremia. Em 134 cães (83,2%) foram descritos sinais clínicos associados à uremia. As lesões extrarrenais mais frequentes, em ordem decrescente, foram: gastrite ulcerativa e hemorrágica (56,5%), mineralização de tecidos moles (55,9%), edema pulmonar (47,2%), estomatite e/ou glossite ulcerativa (30,4%), endocardite/trombose atrial e aórtica (28,6%), hiperplasia das paratireoides (9,3%), osteodistrofia fibrosa (8,1%), anemia (6,2%), laringite ulcerativa (5%), enterite ulcerativa/hemorrágica (3,7%), esofagite fibrinonecrótica (1,9%) e pericardite fibrinosa (1.9%). Na maioria dos casos as lesões extrarrenais de uremia foram decorrentes de azotemia prolongada por lesões renais graves, sendo as mais prevalentes a nefrite intersticial e a glomerulonefrite.

Estudo anatômico comparativo entre formas normais e estruturas teratogênicas provocadas por 2,4 -D em cana-de-açúcar

A aplicação do herbicida 2,4-D amina, para controlar plantas daninhas em cultura de cana-de-açúcar, produziu estruturas anormais e afetou a própria cultura da cana. Foram estuda das as alterações anatômicas e organográfícas dessas formas teratogénicas e comparadas com as estruturas normais. Foram observadas deformações no colmo que apresentou curvatur as e entrenós mais finos e curtos; o sistema radicular apresentou-se pouco desenvolvido. Na região do anel meristemático e saída das raízes adventícias, observou-se um intumescimento com tumoração e posterior necrose. Anatomicamente, na região do anel meristemático, a epiderme e o parênquima cortical apresentaram células hipertrofíadas e crescimento desordenado; houve malformação de feixes fibrovasculares. Na região das raízes adventícias foi observada tumoração com acentuada hiperplasia e necrose na periferia.

Crescimento e morfoanatomia foliar de eucalipto sob efeito de deriva do glyphosate

Os efeitos da deriva do glyphosate durante aplicação são prejudiciais à cultura do eucalipto. Neste trabalho, avaliou-se o efeito da deriva simulada do glyphosate no crescimento e na morfoanatomia foliar do eucalipto. Utilizou-se delineamento em blocos casualizados com quatro repetições, sendo a parcela experimental constituída de uma planta cultivada em vaso com 10 litros de solo. Os tratamentos foram 0; 43,2; 86,4; 172,8; e 345,6 g e.a. ha-1 de glyphosate, aplicados aos 40 dias após o plantio das mudas com pulverizador de precisão, de modo a não atingir o terço superior das plantas. Foram descritas as alterações morfológicas na parte aérea e avaliada a porcentagem de intoxicação em relação à testemunha. Aos 7 e 15 dias após aplicação (DAA), folhas coletadas no terceiro nó do primeiro ramo basal das plantas foram fixadas em FAA50 e estocadas em etanol 70%. Cortes transversais da região mediana foram corados com azul de astra e fucsina básica e montados em lâminas permanentes. No laminário preparado foram mensuradas as espessuras do limbo, do parênquima paliçádico (PPA) e lacunoso (PLA), da epiderme das faces adaxial (EAD) e abaxial (EAB), bem como a proporção percentual da área de cada tecido, utilizando-se o software Image-Pro Plus. A partir de 5 DAA observou-se murcha, clorose e enrolamento das folhas nos ápices das plantas pulverizadas com 172,8 e 345,6 g ha¹ de glyphosate. As plantas submetidas a 345,6 g e.a. ha¹ de glyphosate alcançaram 58,75% de toxidez aos 30 DAA, apresentando brotações anormais, o que não foi verificado nas concentrações menores. Aos 7 e 15 DAA, com 172,8 e 345,6 g e.a. ha¹ de glyphosate observaram-se áreas necrosadas e hiperplasia das células do parênquima clorofiliano e da epiderme. Em resposta à injúria, verificou-se a proliferação celular, formando tecido de cicatrização homogêneo, além de acúmulo de compostos fenólicos nas áreas afetadas. Aos 7 DAA verificou-se aumento na espessura do limbo e do PPA submetidos a 345,6 g e.a. ha¹ de glyphosate, enquanto o PLA e a EAD demonstraram acréscimo na espessura somente aos 15 DAA sob a mesma dosagem. As doses de 172,8 e 345,6 g e.a. ha-1 de glyphosate promoveram aumento na espessura do limbo e do PPA aos 15 DAA. O aumento na espessura do limbo é resultante da expansão das células do parênquima paliçádico, podendo estar relacionado à resposta das plantas à perda de área foliar específica, bem como à síntese de compostos secundários, como celulases, provocados pela ação do glyphosate.

Reações de defesas químicas e estruturais de Lonchocarpus muehlbergianus Hassl. (Fabaceae) à ação do galhador Euphalerus ostreoides Crawf. (Hemiptera: Psyllidae)

Galhas são estruturas vegetais induzidas em resposta ao ataque de organismos indutores. Euphalerus ostreoides (Psyllidae) induz galhas sobre a face adaxial de folíolos nas nervuras de segunda ordem de Lonchocarpus muehlbergianus (Fabaceae). Seções anatômicas foram realizadas e comparados os tecidos de folíolos sadios com os de galhas imaturas e maduras. Testes histoquímicos para detecção de derivados fenólicos, flavonóides, ligninas, lipídios e amido foram realizados para avaliar o impacto químico causado pelo galhador. Em termos estruturais, a perda de sinuosidade das células epidérmicas, a neoformação de tricomas, de células condutoras e de fibras foram os caracteres mais conspícuos observados em decorrência da indução das galhas. Destaca-se a hiperplasia e hipetrofia do mesofilo com manutenção da estratificação, a produção de gotículas lipídicas e amido, flavonas, flavonóis e flavanonas nos tecidos das galhas. Contudo, a formação de cristais de oxônio pela adição de ácido sulfúrico somente nos tecidos das galhas foi uma característica marcante. Os resultados sugerem que L. muehlbergianus está submetida a alto estresse oxidativo induzido pela ação do E. ostreoides. Conclui-se que as alterações são consideradas reações de defesa da planta contra herbivoria e mecanismos de adaptação que em conjunto favorecem o estabelecimento do galhador nos tecidos vegetais.

Ontogênese da folha e das galhas induzidas por Aceria lantanae Cook (Acarina:Eriophyidae) em Lantanacamara L. (Verbenaceae)

Aceria lantanae é um ácaro fitófago indutor de galhas em folhas de Lantana camara. O estudo comparativo de caracteres histológicos e histométricos durante a ontogênese foliar e das galhas visa determinar quais eventos da morfogênese dos tecidos sadios são alterados pelo galhador. A ontogênese foliar de L. camara segue os padrões descritos na literatura. A indução de galhas provoca hiperplasia da epiderme e do sistema fundamental. No estágio de crescimento e desenvolvimento, a invaginação da lâmina foliar origina a câmara ninfal, onde os eriofídeos se reproduzem. O revestimento interno dessa câmara constitui o tecido nutritivo, no qual os indutores se alimentam, estimulando as divisões celulares. No estágio de maturação, o aumento no tamanho da estrutura é acompanhado pelo aumento no número de indivíduos de A. lantanae. O revestimento externo da galha apresenta alta densidade de tricomas tectores, cujo morfotipo é particular às galhas. A diferenciação de emergências e a neoformação de feixes vasculares promove o aporte de nutrientes aos indutores. Divisões celulares em diversos planos alteram o padrão laminar da folha resultando em galhas verrucosas. O arranjo dos tecidos antes direcionados à fotossíntese passa a garantir um microambiente adequado e fonte nutricional para a colônia de A. lantanae. No estágio de senescência, a suberização do tecido nutritivo indica o fim da atividade alimentar dos indutores. O fim dos ciclos celulares tem lugar com a suberização do tecido nutritivo, evento que pode ser relacionado à morte da fêmea deutogina, ou ao limite imposto pela idade da folha hospedeira de L. camara.

Histopathological diagnosis of intra- and extrahepatic neonatal cholestasis

The histopathology of the liver is fundamental for the differential diagnosis between intra- and extrahepatic causes of neonatal cholestasis. However, histopathological findings may overlap and there is disagreement among authors concerning those which could discriminate between intra- and extrahepatic cholestasis. Forty-six liver biopsies (35 wedge biopsies and 11 percutaneous biopsies) and one specimen from a postmortem examination, all from patients hospitalized for neonatal cholestasis in the Pediatrics Service of Hospital de Clínicas de Porto Alegre, were prospectively studied using a specially designed histopathological protocol. At least 4 of 5 different stains were used, and 46 hepatic histopathological variables related to the differential diagnosis of neonatal cholestasis were studied. The findings were scored for severity on a scale from 0 to 4. Sections which showed less than 3 portal spaces were excluded from the study. Sections were examined by a pathologist who was unaware of the final diagnosis of each case. Bile tract permeability was defined by scintigraphy of the bile ducts and operative cholangiography. The F test and discriminant analysis were used as statistical methods for the study of the hepatic histopathological variables. The chi-square method with Yates correction was used to relate the age of the patients on the date of the histopathological study to the discriminatory variables between intra- and extrahepatic cholestasis selected by the discriminant function test. The most valuable hepatic histopathological variables for the discrimination between intra- and extrahepatic cholestasis, in decreasing order of importance, were periportal ductal proliferation, portal ductal proliferation, portal expansion, cholestasis in neoductules, foci of myeloid metaplasia, and portal-portal bridges. The only variable which pointed to the diagnosis of intrahepatic cholestasis was myeloid metaplasia. Due to the small number of patients who were younger than 60 days on the date of the histopathological study (N = 6), no variable discriminated between intra- and extrahepatic cholestasis before the age of 2 months and all of them, except for the portal expansion, were discriminatory after this age. In infants with cholestasis, foci of myeloid metaplasia, whenever present in the liver biopsy, suggested intrahepatic cholestasis. Periportal ductal proliferation, portal ductal proliferation, portal expansion, cholestasis in neoductules, portal cholestasis and portal-portal bridges suggested extrahepatic obstructive cholestasis.

Microencapsulation and tissue engineering as an alternative treatment of diabetes

In the 70's, pancreatic islet transplantation arose as an attractive alternative to restore normoglycemia; however, the scarcity of donors and difficulties with allotransplants, even under immunosuppressive treatment, greatly hampered the use of this alternative. Several materials and devices have been developed to circumvent the problem of islet rejection by the recipient, but, so far, none has proved to be totally effective. A major barrier to transpose is the highly organized islet architecture and its physical and chemical setting in the pancreatic parenchyma. In order to tackle this problem, we assembled a multidisciplinary team that has been working towards setting up the Human Pancreatic Islets Unit at the Chemistry Institute of the University of São Paulo, to collect and process pancreas from human donors, upon consent, in order to produce purified, viable and functional islets to be used in transplants. Collaboration with the private enterprise has allowed access to the latest developed biomaterials for islet encapsulation and immunoisolation. Reasoning that the natural islet microenvironment should be mimicked for optimum viability and function, we set out to isolate extracellular matrix components from human pancreas, not only for analytical purposes, but also to be used as supplementary components of encapsulating materials. A protocol was designed to routinely culture different pancreatic tissues (islets, parenchyma and ducts) in the presence of several pancreatic extracellular matrix components and peptide growth factors to enrich the beta cell population in vitro before transplantation into patients. In addition to representing a therapeutic promise, this initiative is an example of productive partnership between the medical and scientific sectors of the university and private enterprises.

Lack of mutations of exon 2 of the MEN1 gene in endocrine and nonendocrine sporadic tumors

In addition to the mutations that underlie most cases of the multiple endocrine neoplasia type 1 (MEN1) syndrome, somatic mutations of the MEN1 gene have also been described in sporadic tumors like gastrinomas, insulinomas and bronchial carcinoid neoplasm. We examined exon 2 of this gene, where most of the mutations have been described, in 148 endocrine and nonendocrine sporadic tumors. DNA was obtained by phenol/chloroform extraction and ethanol precipitation from 92 formalin-fixed, paraffin-embedded samples, and from 40 fresh tumor tissue samples. We used 5 pairs of primers to encompass the complete coding sequence of exon 2 of the MEN1 gene that was screened by the polymerase chain reaction-single-stranded conformation polymorphism (PCR-SSCP) technique in 78 sporadic thyroid cancers: 28 follicular adenomas, 35 papillary carcinomas, 14 follicular carcinomas, and 1 anaplastic thyroid carcinoma. We also examined 46 adrenal lesions (3 hyperplasias, 3 adenomas and 35 adrenocortical carcinomas, 2 pheochromocytomas, 2 ganglioneuroblastomas, and 1 lymphoma) and 24 breast cancers (6 noninvasive, 16 infiltrating ductal, and 2 invasive lobular tumors). The PCR product of 5 tumors suspected to present band shifts by SSCP was cloned. Direct sense and antisense sequencing did not identify mutations. These results suggest that the MEN1 gene is not important in breast, thyroid or adrenal sporadic tumorigenesis. Because the frequency of mutations varies significantly among tumor subgroups and allelic deletions are frequently observed at 11q13 in thyroid and adrenal cancers, another tumor suppressor gene residing in this region is likely to be involved in the tumorigenesis of these neoplasms.

Does the correlation between EBNA-1 and p63 expression in breast carcinomas provide a clue to tumorigenesis in Epstein-Barr virus-related breast malignancies?

Several investigators have identified Epstein-Barr virus (EBV) particles in breast carcinomas, a fact that supports a role for EBV in mammary tumorigenesis. The possible mechanism involved in this process is not clear. The present study was carried out in an attempt to determine whether there is a relationship between latent infection with EBV and p53 and p63 expression in breast carcinomas. Immunohistochemistry developed with 3.3-diaminobenzidine tetrahydrochloride was performed in 85 formalin-fixed paraffin-embedded breast carcinomas using anti-EBV EBNA-1, anti-p63, anti-p53, anti-estrogen receptor (ER) and anti-progesterone receptor (PR) antibodies. The cases were selected to represent each of the various histologic types: intraductal carcinoma (N = 12), grade I invasive ductal carcinoma (N = 15), grade II invasive ductal carcinoma (N = 15), grade III invasive ductal carcinoma (N = 15), tubular carcinoma (N = 8), lobular carcinoma (N = 10), and medullary carcinoma (N = 10). The ductal breast carcinomas were graded I, II and III based on the Scarff-Bloom and Richardson grading system modified by Elston and Ellis. One slide containing at least 1000 neoplastic cells was examined in each case. ER, PR, p63, p53 and EBNA-1 were positive in 60, 40, 11.8, 21.2 and 37.6% of carcinomas, respectively. There was a correlation between EBNA-1 and p63 expression (P < 0.001), but not between EBNA-1 and p53 (P = 0.10). These data suggest a possible role for p63 in the mammary tumorigenesis associated with Epstein-Barr virus infection.

Morphological changes induced by testosterone in the mammary glands of female Wistar rats

Increased levels of androgens in postmenopausal women are considered to be a risk factor for breast cancer. Testosterone, alone or in combination with estrogen, induces epithelial dysplasia and mammary tumors in Noble rats. Since this model of hormone-induced neoplasia has not been reported in other rat strains, we studied the effect of testosterone on the mammary gland morphology of female Wistar rats. Sixty adult, non-castrated, female Wistar rats were implanted in the dorsum midline with a silicone tube containing 50 mg testosterone (testosterone propionate in 30 animals and non-esterified testosterone in the remaining 30 animals) and 20 additional animals were implanted with empty tubes and used as control. Five animals per group were killed 30, 60, 90, 120, 150, and 180 days after implantation, and the mammary glands were dissected, fixed and embedded in paraffin. Histological sections were then stained with hematoxylin and eosin and picrosyrius red for collagen visualization. Morphological and morphometric analysis demonstrated ductal proliferation and acinotubular differentiation with secretory activity in all treated animals, peaking at 90 days of androgen exposure. After 90 days the proliferation of acinar epithelial cells was evident, but there was a progressive reduction of secretory differentiation and an increase in intralobular collagen fibers. There was no morphological evidence of dysplastic changes or other pre-neoplastic lesions. Testosterone treatment applied to adult, non-castrated female Wistar rats induced a mammary gland hyperplasia resembling the lactating differentiation, with progressive reduction in secretory differentiation.

Secondary prevention of type 1 diabetes mellitus: stopping immune destruction and promoting ß-cell regeneration

Type 1 diabetes mellitus results from a cell-mediated autoimmune attack against pancreatic ß-cells. Traditional treatments involve numerous daily insulin dosages/injections and rigorous glucose control. Many efforts toward the identification of ß-cell precursors have been made not only with the aim of understanding the physiology of islet regeneration, but also as an alternative way to produce ß-cells to be used in protocols of islet transplantation. In this review, we summarize the most recent studies related to precursor cells implicated in the regeneration process. These include embryonic stem cells, pancreas-derived multipotent precursors, pancreatic ductal cells, hematopoietic stem cells, mesenchymal stem cells, hepatic oval cells, and mature ß-cells. There is controversial evidence of the potential of these cell sources to regenerate ß-cell mass in diabetic patients. However, clinical trials using embryonic stem cells, umbilical cord blood or adult bone marrow stem cells are under way. The results of various immunosuppressive regimens aiming at blocking autoimmunity against pancreatic ß-cells and promoting ß-cell preservation are also analyzed. Most of these regimens provide transient and partial effect on insulin requirements, but new regimens are beginning to be tested. Our own clinical trial combines a high dose immunosuppression with mobilized peripheral blood hematopoietic stem cell transplantation in early-onset type 1 diabetes mellitus.

Molecular and cellular pathogenesis of autosomal recessive polycystic kidney disease

Autosomal recessive polycystic kidney disease (ARPKD) is an inherited disease characterized by a malformation complex which includes cystically dilated tubules in the kidneys and ductal plate malformation in the liver. The disorder is observed primarily in infancy and childhood, being responsible for significant pediatric morbidity and mortality. All typical forms of ARPKD are caused by mutations in a single gene, PKHD1 (polycystic kidney and hepatic disease 1). This gene has a minimum of 86 exons, assembled into multiple differentially spliced transcripts and has its highest level of expression in kidney, pancreas and liver. Mutational analyses revealed that all patients with both mutations associated with truncation of the longest open reading frame-encoded protein displayed the severe phenotype. This product, polyductin, is a 4,074-amino acid protein expressed in the cytoplasm, plasma membrane and primary apical cilia, a structure that has been implicated in the pathogenesis of different polycystic kidney diseases. In fact, cholangiocytes isolated from an ARPKD rat model develop shorter and dysmorphic cilia, suggesting polyductin to be important for normal ciliary morphology. Polyductin seems also to participate in tubule morphogenesis and cell mitotic orientation along the tubular axis. The recent advances in the understanding of in vitro and animal models of polycystic kidney diseases have shed light on the molecular and cellular mechanisms of cyst formation and progression, allowing the initiation of therapeutic strategy designing and promising perspectives for ARPKD patients. It is notable that vasopressin V2 receptor antagonists can inhibit/halt the renal cystic disease progression in an orthologous rat model of human ARPKD.

Prevalence of vascular-endothelial growth factor, matrix metalloproteinases and tissue inhibitors of metalloproteinases in primary breast cancer

Our objective was to determine the presence of vascular endothelial growth factor (VEGF), matrix metalloproteinase-2 (MMP-2) and MMP-9 and specific tissue inhibitors of matrix metalloproteinase (TIMP-1 and TIMP-2) in tumor samples obtained from patients with primary breast cancer. We attempted to correlate these findings with the status of the sentinel lymph node (SLN) and clinical-pathological characteristics such as age, tumor size, histological type, histological grade, and vascular invasion. Tumor samples from 88 patients with primary breast cancer were analyzed. The immunoreactivity of VEGF, MMP-2, MMP-9, TIMP-1, and TIMP-2 in tumors was correlated with clinical and pathological features, as well as SLN status. Nonparametric, Mann-Whittney, Kruskal-Wallis, and Spearmann tests were used. Categorical variables were analyzed by the Pearson test. No statistically significant correlation was found between the amount of VEGF, MMP-2, MMP-9, TIMP-1, and TIMP-2 and the presence of tumor cells in the SLN. However, larger tumor diameter (P < 0.01) and the presence of vascular invasion (P < 0.01) were correlated positively with a positive SLN. A significant correlation of higher VEGF levels (P = 0.04) and lower TIMP-1 levels (P = 0.04) with ductal histology was also observed. Furthermore, lower TIMP-2 levels showed a statistically significant correlation with younger age (<50 years) and larger tumor diameter (2.0-5.0 cm). A positive SLN correlated significantly with a larger tumor diameter and the presence of vascular invasion. Higher VEGF and lower TIMP-1 levels were observed in patients with ductal tumors, while higher TIMP-1 levels were observed in lobular tumors.

Sentinel node biopsy in breast cancer: results in a large series

Sentinel lymph node biopsy (SLNB) is an appropriate method for the evaluation of axillary status in cases of early breast cancer. We report our experience in treating cases evaluated using SLNB. We analyzed a total of 1192 cases assessed by means of SLNB from July 1999 to December 2007. SLNB processing was successfully completed in 1154 cases with the use of blue dye or radiolabeled 99mTc-Dextran-500, or both. Of these 1154 patients, 857 were N0(i-) (no regional lymph node metastasis, negative immunohistochemistry, IHC), 96 were N0(i+) (no regional lymph node metastasis histologically, positive IHC, no IHC cluster greater than 0.2 mm) and 201 were N1mi (greater than 0.2 mm, none greater than 2.0 mm). Most of the tumors (70%) were invasive ductal carcinomas and tumors were staged as T1 in 770 patients (65%). A total of 274 patients underwent SLNB and axillary dissections up to April 2003. The inclusion criteria were tumor size equal to or less than 3 cm in diameter, no clinically palpable axillary lymph nodes, no neoadjuvant therapy. In 19 cases, the SLN could not be identified intraoperatively. A false-negative rate of 11% and a negative predictive value of 88.2% were obtained for the 255 assessable patients. The overall concordance between SLNB and axillary lymph node status was 92%. SLNB sensitivity for nodes was 81% and specificity was 100%. The higher sensitivity, specificity, accuracy, and lower false-negative rates of SLNB suggest that this method may be an appropriate alternative to total axillary dissection in early breast cancer patients.